Skip to content
Open access · US-GOV via ClinicalTrials.gov Clinical trial

Altering Mechanisms of Frailty in Persons Living With HIV Aged 50 to 65

Authors not listed

University of Maryland, Baltimore · 2020

Abstract

People living with HIV are living longer as their disease is controlled with antiretroviral medications. Yet they are experiencing frailty more often and more than ten years earlier than those without HIV. In elderly persons without HIV, frailty is associated with decreased muscle strength and chronic inflammation. Less is known about what is driving early frailty in HIV or effective prevention measures for aging adults with HIV. It may be that having HIV infection impairs energy production by mitochondria within the cells and contributes to the muscle weakness and inflammation accompanying frailty in people living with HIV . This study will examine the impact of six weeks of moderately paced walking on energy production in the cells, inflammation markers and frailty scores in people living with well-controlled HIV who are aged 50 to 65.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
ClinicalTrials.gov
Canonical
link ↗
Fetched
2026-10-15 MST

Cite this

APA
Anonymous. (2020). Altering Mechanisms of Frailty in Persons Living With HIV Aged 50 to 65. <em>University of Maryland, Baltimore</em>. https://clinicaltrials.gov/study/NCT04321603
Vancouver
Anonymous. Altering Mechanisms of Frailty in Persons Living With HIV Aged 50 to 65. University of Maryland, Baltimore. 2020.
BibTeX
@misc{anon2020Alteri, title = {Altering Mechanisms of Frailty in Persons Living With HIV Aged 50 to 65}, author = {Anonymous}, journal = {University of Maryland, Baltimore}, year = {2020}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings